Print page

Email page

Combating Counterfeiting and Illegal Diversion

By Jim Whittle, vice president of business development, NanoInk, Inc.

PharmaManufacturing.com

Unit dosage protection measures created by NanoInk's Nanoencryption technology provide complete traceability and ensure that patients are receiving the right medication.

Jim Whittle, vice president of business development for NanoInk, Inc., led an interactive workshop on combating counterfeiting and illegal diversion of pharmaceuticals on Sept. 19 at the Global Pharma Manufacturing Summit in Schaumburg, Ill. Click below to access his 61-page PowerPoint presentation.